慢性血栓栓塞性肺动脉高压患者中68 Ga-FAPI-04肺动脉显像
本研究在13例慢性血栓栓塞性肺动脉高压(CTEPH)患者与13例匹配的非CTEPH对照者中评估肺动脉及升主动脉对68 Ga-FAPI-04的摄取,并分析其与右心导管指标的相关性。结果显示9例(69%)CTEPH患者肺动脉出现视觉增强摄取,对照组无1例出现;肺动脉68 Ga-FAPI-04活性与肺动脉舒张压呈正相关(r=0.571,P=0.041)。作者认为68 Ga-FAPI-04有潜力用于肺动脉壁成纤维细胞活化的显像。
要点
- 13例CTEPH患者中9例(69%)肺动脉68 Ga-FAPI-04摄取视觉增强,13例对照者均无增强。
- 主肺动脉、肺叶及肺段动脉增强摄取比例分别为45%(17/38)、33%(16/48)及28%(44/159)。
- 肺动脉68 Ga-FAPI-04活性与肺动脉舒张压正相关(r=0.571,P=0.041)。
核心结论
- 68 Ga-FAPI-04有潜力用于肺动脉壁成纤维细胞活化的显像,且肺动脉68 Ga-FAPI-04活性与肺动脉舒张压呈正相关。
研究设计与样本
- 研究纳入13例CTEPH患者与13例匹配的非CTEPH对照者,评估肺动脉及升主动脉对68 Ga-FAPI-04的摄取。
- 分析肺动脉68 Ga-FAPI-04摄取与右心导管(RHC)所得重构参数的相关性。
主要发现
- 13例CTEPH患者中9例(69%)肺动脉68 Ga-FAPI-04摄取视觉增强,13例对照者肺动脉均无摄取增高。
- 主肺动脉、肺叶动脉及肺段动脉增强摄取比例分别为45%(17/38)、33%(16/48)及28%(44/159)。
- 肺动脉68 Ga-FAPI-04活性与肺动脉舒张压正相关(r=0.571,P=0.041)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The feasibility and significance of imaging pulmonary artery (PA) remodeling with 68 Ga-fibroblast activating protein inhibitor (FAPI) in patients with chronic thromboembolic pulmonary hypertension (CTEPH) have not yet been addressed. METHODS: 68 Ga-FAPI-04 uptake in the PA and ascending artery was evaluated in 13 patients with CTEPH and 13 matched non-CTEPH controls. The correlations of PA 68 Ga-FAPI-04 uptake and remodeling parameters derived from right heart catheterization (RHC) were analyzed. RESULTS: Of the 13 patients with CTEPH, nine (69%) showed visually enhanced 68 Ga-FAPI-04 uptake, whereas none of the control subjects had increased 68 Ga-FAPI-04 uptake in the PA. The prevalence of enhanced uptake in the main, lobar, and segmental PAs was 45% (17/38), 33% (16/48), and 28% (44/159), respectively. 68 Ga-FAPI-04 activity in the PA was positively correlated with pulmonary arterial diastolic pressure (r = 0.571, P = 0.041). CONCLUSION: 68 Ga-FAPI-04 has the potential for imaging fibroblast activation in the PA wall, and 68 Ga-FAPI-04 activity in PA is positively correlated with pulmonary arterial diastolic pressure.
引用
- Gong JN, Chen BX, Xing HQ, et al. Pulmonary artery imaging with 68 Ga-FAPI-04 in patients with chronic thromboembolic pulmonary hypertension. J Nucl Cardiol. 2022. PMID: 35927377. doi:10.1007/s12350-022-03069-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。